Literature DB >> 1562194

Regulation of net hepatic glucose uptake in vivo.

M J Pagliassotti1, A D Cherrington.   

Abstract

Increases in the glucose level in the absence of the portal signal or changes in insulin elicits little if any glucose uptake by the liver. NHGU is augmented by a rise in insulin (or drop in glucagon) and is further stimulated by the presence of a portal signal. Under postprandial conditions, NHGU will depend on the dynamic interaction between the pancreatic hormones, glucose and the portal signal. Moreover, in a simulated postprandial environment, the quantitative impact of the portal signal is at least as important as that of insulin. The presence of the portal signal should be of physiologic benefit because it will allow adequate net removal of glucose by the liver without requiring excessive excursions of insulin and glucose. The metabolic fate of ingested glucose within the liver is still controversial. It appears that the liver will remove 30-40% of the glucose that enters the portal vein following an oral glucose load and will replete its glycogen stores by both direct and indirect pathways. Whether the three-carbon precursors utilized by the indirect route are of hepatic or peripheral origin remains a matter of debate. Studies are under way to elucidate whether the hepatic response to the portal signal involves the autonomic nervous system, the nature of the interaction of the portal signal and insulin, and the metabolic fate of glucose removed by the liver in response to this signal.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1562194     DOI: 10.1146/annurev.ph.54.030192.004215

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  24 in total

Review 1.  Blood glucose management during critical illness.

Authors:  Barry A Mizock
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.

Authors:  Hana Alkhalidy; Will Moore; Aihua Wang; Jing Luo; Ryan P McMillan; Yao Wang; Wei Zhen; Matthew W Hulver; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-01       Impact factor: 6.048

Review 3.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

4.  Role of peroxisome proliferator-activated receptor {delta}/{beta} in hepatic metabolic regulation.

Authors:  Sihao Liu; Ben Hatano; Minghui Zhao; Chen-Chung Yen; Kihwa Kang; Shannon M Reilly; Matthew R Gangl; Cem Gorgun; James A Balschi; James M Ntambi; Chih-Hao Lee
Journal:  J Biol Chem       Date:  2010-11-08       Impact factor: 5.157

5.  A noninvasive method to measure splanchnic glucose uptake after oral glucose administration.

Authors:  B Ludvik; J J Nolan; A Roberts; J Baloga; M Joyce; J M Bell; J M Olefsky
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 6.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

7.  Maternal exercise improves insulin sensitivity in mature rat offspring.

Authors:  Lindsay G Carter; Nathan R Qi; Rafael De Cabo; Kevin J Pearson
Journal:  Med Sci Sports Exerc       Date:  2013-05       Impact factor: 5.411

8.  A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo.

Authors:  Zhibo An; Jason J Winnick; Ben Farmer; Doss Neal; Margaret Lautz; Jose M Irimia; Peter J Roach; Alan D Cherrington
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

9.  Portal glucose infusion-glucose clamp measures hepatic influence on postprandial systemic glucose appearance as well as whole body glucose disposal.

Authors:  Dan Zheng; Viorica Ionut; Vahe Mooradian; Darko Stefanovski; Richard N Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-24       Impact factor: 4.310

Review 10.  [Future targets in the treatment of type 2 diabetes].

Authors:  Harald Stingl; Michael Roden
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.